• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    64.74 Down 3.67(5.36%) Feb 8, 4:00PM EST
    |After Hours : 63.52 Down 1.22 (1.88%) Feb 8, 7:38PM EST
    Prev Close:68.41
    Open:68.17
    Bid:N/A
    Ask:97.87 x 100
    1y Target Est:132.72
    Beta:1.7992
    Next Earnings Date:25-Feb-16BMRN Earnings announcement
    Day's Range:63.71 - 68.17
    52wk Range:63.71 - 151.75
    Volume:1,839,042
    Avg Vol (3m):1,623,440
    Market Cap:10.44B
    P/E (ttm):N/A
    EPS (ttm):-1.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 5.36%10.44B
    FOLDDown 13.86%645.14M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Dec-15) :0.67
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-4.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback